ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 390

Prevalence and Correlates of Patient-Physician Discordance in Early Rheumatoid Arthritis

John M. Davis III1, Cynthia S. Crowson2, Tim Bongartz1, Clement J. Michet1, Eric L. Matteson1 and Sherine E. Gabriel3, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Health Sciences Research, Mayo Clinic, Rochester, MN, 3Health Sciences Research & Div of Rheumatology, Mayo Clinic, Rochester, MN

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Disease Activity, Health Assessment Questionnaire, pain and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects: Novel Biomarkers and Other Measurements of Disease Activity

Session Type: Abstract Submissions (ACR)

Background/Purpose

Patients with rheumatoid arthritis (RA) sometimes rate their global disease activity differently than their rheumatologists.  Previous studies describing this ‘discordance’ have primarily included patients with established disease (i.e., mean disease duration >10 years).  The objective of this study was to evaluate the prevalence and correlates of patient-physician discordance in patients with early disease (i.e., duration <3 years).

Methods

We conducted an observational study of consecutive patients with RA recruited between July 2008 and December 2010.  RA was defined by the Leiden early RA prediction rule or the 1987 ACR criteria.  A physician joint assessor, who was independent from treatment decision-making, performed a standardized clinical evaluation.  Discordance was defined by a ≥25-mm difference between the patient and physician global assessments of disease activity.  A higher patient-than-physician global assessment defined positive discordance, and a higher physician-than-patient global assessment defined negative discordance.  Patients completed visual analog scales for pain and fatigue, the Health Assessment Questionnaire (HAQ), and the Medical Outcomes Study Short Form 36 (SF-36).  We abstracted the electronic medical records to collect demographics, laboratory data, smoking status, and body mass index (kg/m2).  Correlations between explanatory variables and the presence of positive or negative discordance were determined using Spearman methods.

Results

A total of 127 patients with RA were recruited.  The mean age was 55.6 years, mean disease duration was 6.8 months, and 63% of patients were female.  The prevalence of positive (i.e., patient high) and negative (i.e., physician high) discordance was 10.2% and 16.5%, respectively.  Positive discordance was associated with higher pain (r = 0.37, p = <0.001), fatigue (r = 0.32, <0.001) and HAQ disability (r = 0.31, p<0.001).  Poor health-related quality of life on the SF-36 physical component scale (r = -0.29, p = 0.001) and mental component scale (r = -0.20, p = 0.02) also correlated with positive discordance.  Notably absent were associations of discordance with age, sex, radiographic damage, body mass index, smoking, anti-CCP antibodies, or use of prednisone or disease-modifying medications.  In contrast, negative discordance (i.e., physician high) was associated with higher numbers of swollen joints (r = 0.19, p = 0.03), positive rheumatoid factor (r = 0.18, p = 0.046), and with lower pain and better overall physical and mental health on the part of the patient.

Conclusion

The contribution of this study is that prevalence and correlates of patient-physician discordance are similar in early and established RA.  Patients with early RA take into account their pain, fatigue and adverse quality of life when making their global disease assessments whereas physicians emphasize objective inflammation and laboratory markers.  As ‘treat-to-target’ algorithms increasingly focus on quantitative targets, these data behoove clinicians to fully consider the disease experience to provide optimal patient care.


Disclosure:

J. M. Davis III,
None;

C. S. Crowson,
None;

T. Bongartz,
None;

C. J. Michet,
None;

E. L. Matteson,
None;

S. E. Gabriel,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-and-correlates-of-patient-physician-discordance-in-early-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology